Back to MILLENNIUM MANAGEMENT LLC MILLENNIUM MANAGEMENT LLC

CGEMCGEM
Showing 8 of 21 quarters

Position history for MILLENNIUM MANAGEMENT LLCMILLENNIUM MANAGEMENT LLC's holdings in CULLINAN THERAPEUTICS INC

Yes. Millennium Management holds 346,232 shares of CGEM (Cullinan Therapeutics), worth $6.3M, as of its Q2 2026 13F filing. It reduced the position by 350 shares (-0.1%) from Q1 2026. Millennium Management has held CGEM since Q3 2024, across 8 quarterly 13F filings.

Current Value

$6.3M

Current Shares

346,232

Total Value Change

-$6.9M

Total Shares Change

-442,335

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
346,232
-0.1%
$6.3M0.0%$18.21
0
2026-Q1
Decreased
346,582
-4.4%
$4.9M0.0%$15.73
0
2025-Q4
Decreased
362,495
-34.1%
$3.8M0.0%$9.92
0
2025-Q3
Increased
550,471
+7.8%
$3.3M0.0%$5.97
29
2025-Q2
Decreased
510,828
-34.8%
$3.8M0.0%$7.76
0
2025-Q1
Decreased
783,177
-6.1%
$5.9M0.0%$8.02
0
2024-Q4
Increased
833,962
+5.8%
$10.2M0.0%$12.20
29
2024-Q3
New
788,567
-
$13.2M0.0%$17.19
39

Other major holders of CGEM: BlackRock, Inc., BAUPOST GROUP LLC/MA, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used